21 Dawson Road, West Timperley, Altrincham, Cheshire, WA14 5PF

0161 929 1515 | admin.wtmc@nhs.net

Research practice

West Timperley Medical Centre is a research practice.

Research can:

  • Find new and better ways of preventing, diagnosing and treating diseases or conditions
  • Test new ideas that could improve the lives of people receiving health or social care
  • Look at the costs and benefits of making changes in the community. Examples include introducing exercise programmes or screening for cancer in certain age groups
  • Help us understand how NHS and social care services can run in a more efficient way.

For more information visit the National Institute for Health and Care Research website.

When research projects become available, we will post them on this web page. This will include a little information about each study.

Our partnership with the uMed research platform

West Timperley Medical Centre is currently working with a research technology partner known as uMed. Their accredited platform enables us to provide you with research opportunities that are highly relevant to your health circumstances.

Without the use of uMed’s technology we may not have the time to find and engage patients that meet the requirements of the studies. This would therefore mean many patients would miss out on their chance to participate in ground-breaking research.

For further information on uMed please visit their website at www.umed.io or email patientsupport@umed.io

Practice Privacy Notice Statement Supporting Research Activity

West Timperley Medical Centre uses Umedeor Ltd (uMed) as a data processor to support research and care support activity. This includes accessing and secure hosting of health record data for the purpose of identifying patients that are eligible for specific research or care support projects. uMed also contacts those patients on behalf of the practice via SMS, letter, email or telephone to provide more information about the study, and to collect additional information to assess your eligibility for a certain study.

Your consent will be required before any practice data is shared externally with researchers. uMed applies the national opt-out to practice data it receives so if you wish your data is not processed for research you can do so by visiting https://www.nhs.uk/your-nhs-data-matters/

For further information on uMed please visit their website at www.umed.io or email patientsupport@umed.io

ACCESS Registries

West Timperley Medical Centre is taking part in several studies known as ACCESS Registries, run by our research technology partner uMed. These registry studies follow participants over time and collect information provided by you, on your own terms, from the comfort of your own home. This provides researchers with invaluable data about different diseases and conditions. The data collection can be in the form of questionnaires, medical device data and DNA testing.

These ACCESS Registries are currently enrolling patients who have been diagnosed with the following conditions:

  • Parkinson’s Disease (AccessPD registry)
  • Interstitial Lung Disease (AccessILD registry)
  • Cardiometabolic Disease (AccessCMD registry)

If you’d like to find out more about these studies and what would be involved if you decided to participate please contact uMed’s nurse support team at patientsupport@umed.io

The PILLAR study

The World Health Organization estimates that 65 million people worldwide have moderate to severe COPD. Although maintenance therapies are available to help maintain regular breathing, some people still have symptoms or experience exacerbations which can result in a hospital admission, even when prescribed a combination of all 3 therapies.

West Timperley Medical Centre is taking part in the PILLAR study which aims to understand whether a new investigational add-on medication will reduce airway inflammation and improve COPD symptoms in people on maintenance triple therapy.

The study is recruiting male or female participants over the age of 40 years, with an established diagnosis of COPD. To be eligible for this study participants will have had chronic bronchitis for at least 3 months in each of the prior two consecutive years, or had a chronic productive cough within the previous year.

West Timperley Medical Centre is working with our research technology partner uMed to invite patients to this study. If you meet the study criteria, you may receive a text message, email or letter asking whether you would like to take part. Participation is entirely voluntary and you can opt out at any time. If you have any questions about this study please contact the uMed nurse support team at patientsupport@umed.io.

Date published: 20th September, 2023
Date last updated: 13th June, 2024